Maccura Biotechnology Co Ltd
300463
Company Profile
Business description
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Contact
Number 8, 2nd Anhe Road
Hi-tech Zone
Chengdu611731
CHNT: +86 2881731888
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
3,472
Stocks News & Analysis
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,135.90 | 19.50 | -0.21% |
| CAC 40 | 7,857.38 | 23.49 | -0.30% |
| DAX 40 | 23,774.57 | 29.51 | 0.12% |
| Dow JONES (US) | 46,316.07 | 68.78 | 0.15% |
| FTSE 100 | 9,316.80 | 16.96 | 0.18% |
| HKSE | 26,855.56 | 232.68 | 0.87% |
| NASDAQ | 22,591.15 | 107.09 | 0.48% |
| Nikkei 225 | 44,932.63 | 111.12 | -0.25% |
| NZX 50 Index | 13,292.36 | 159.80 | 1.22% |
| S&P 500 | 6,661.21 | 17.51 | 0.26% |
| S&P/ASX 200 | 8,848.80 | 20.50 | -0.23% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |